Serial Brain 3D 1H MR Spectroscopy in Multiple Sclerosis

串行脑 3D 1H 磁共振波谱在多发性硬化症中的应用

基本信息

  • 批准号:
    7276603
  • 负责人:
  • 金额:
    $ 57.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-01 至 2010-05-31
  • 项目状态:
    已结题

项目摘要

Clinical T2 and contrast-enhanced Tl-weighted magnetic resonance imaging (MRI) have become the diagnostic modalities of choice in the evaluation of multiple sclerosis (MS) due to their sensitivity to acute, often subclinical events in the brain and their ability to measure the accumulation of the disease over time. MRI, however, lacks specificity, in that to date, there are conflicting reports concerning the number and volume of these lesions, "the load of the disease," and the associated neurological deficits. Furthermore, clinical MRI is completely blind to occult white matter (WM) and most gray matter (GM) pathology. The need for more reliable surrogate markers frequently leads to proton magnetic resonance spectroscopy 1HMRS being used to probe the underlying metabolism of normal appearing WM (NAWM) and the lesions in it. Since MS pathogenesis starts on molecular cellular levels, we propose to use state of the art, short echotime, three-dimensional high-spatial resolution local and global 1H-MRS methods to examine three hypotheses: HI: That MS lesions develop in WM regions which are already metabolically abnormal; H2: Abnormal metabolic activity persists in NAWM and lesions even absent Gd-enhancement (the current marker of "activity"); and H3: That global whole-brain quantification of the decline rate of the neuronal cell marker N-acetylaspartate (NAA) reflects the aggressiveness of a patient's disease, and therefore, could forecast its future course in that individual. These hypotheses will be tested by following a cohort of 25 relapsingremitting (RR) MS patients and 25 matched controls, for 5 years, with three Specific Aims: Specific Aim 1 is to perform longitudinal follow-up of the overall metabolites levels in the NAWM to establish markers for current MRI-occult disease activity. Specific Aim 2 is to follow localized metabolism in NAWM to determine what focal changes preceded lesion formation and determine those lesions' outcome - to repair or become chronic. Specific Aim 3 is to correlate the NAA levels of the whole brain and its WM and GM fractions with the patients' clinical deficits to establish the NAA as a forecaster of disease severity and future course. The health relatedness of this study is its potential to establish, quantify and validate non-invasive radiological metabolic surrogate markers of RR MS progression that will enable us to: (i) Gauge current level of disease activity, thereby, (ii) increase our capability to forecast its future course for these (young) patients; and consequently (iii) lead to improved monitoring of response in drug and treatment trials.
临床T2和对比增强的T1加权磁共振成像(MRI)已成为评估多发性硬化症(MS)的首选诊断方式,因为它们对大脑中急性、通常是亚临床事件的敏感性以及测量累积的能力随着时间的推移疾病。然而,MRI缺乏特异性,因为迄今为止,关于这些病变的数量和体积、"疾病负荷"和相关的神经功能缺损的报道相互矛盾。此外,临床MRI对隐匿性白色物质(WM)和大多数灰质(GM)病理学是完全盲的。对更可靠的替代标记物的需求经常导致质子磁共振波谱1H-MRS被用于探测表现正常的WM(NAWM)的潜在代谢及其病变。由于MS发病机制始于分子细胞水平,我们建议使用最新技术、短回波时间、三维高空间分辨率局部和全局1H-MRS方法来检查三种假设:HI:MS病变发生在已经代谢异常的WM区域; H2:异常代谢活动持续存在于NAWM,病变甚至没有Gd增强("活性"的当前标记);和H3:神经元细胞标志物N-乙酰天冬氨酸(NAA)的下降率的全局全脑定量反映了患者疾病的侵袭性,因此,可以预测它在那个人身上的未来走向。这些假设将通过随访25例复发缓解型(RR)MS患者和25例匹配对照的队列进行检验,随访时间为5年,具体目标有三个:具体目标1是对NAWM中的总体代谢物水平进行纵向随访,以建立当前MRI隐匿性疾病活动的标志物。 具体目标2是跟踪NAWM中的局部代谢,以确定在病变形成之前的病灶变化,并确定这些病变的结果-修复或变为慢性。 具体目标3是将全脑及其WM和GM部分的NAA水平与患者的临床缺陷相关联,以建立NAA作为疾病严重程度和未来病程的预测器。本研究的健康相关性是其建立、量化和验证RR MS进展的非侵入性放射代谢替代标志物的潜力,这将使我们能够:(i)测量疾病活动的当前水平,从而(ii)提高我们预测这些(年轻)患者未来病程的能力;并因此(iii)改善药物和治疗试验中的反应监测。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ODED GONEN其他文献

ODED GONEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ODED GONEN', 18)}}的其他基金

Serial Brain 3D 1H MR Spectroscopy in Multiple Sclerosis
串行脑 3D 1H 磁共振波谱在多发性硬化症中的应用
  • 批准号:
    7116838
  • 财政年份:
    2005
  • 资助金额:
    $ 57.2万
  • 项目类别:
Serial Brain 3D 1H MR Spectroscopy in Multiple Sclerosis
串行脑 3D 1H 磁共振波谱在多发性硬化症中的应用
  • 批准号:
    6970076
  • 财政年份:
    2005
  • 资助金额:
    $ 57.2万
  • 项目类别:
Serial Brain 3D 1H MR Spectroscopy in Multiple Sclerosis
串行脑 3D 1H 磁共振波谱在多发性硬化症中的应用
  • 批准号:
    7658167
  • 财政年份:
    2005
  • 资助金额:
    $ 57.2万
  • 项目类别:
Serial Brain 3D 1H MR Spectroscopy in Multiple Sclerosis
串行脑 3D 1H 磁共振波谱在多发性硬化症中的应用
  • 批准号:
    7417492
  • 财政年份:
    2005
  • 资助金额:
    $ 57.2万
  • 项目类别:
Serial Brain 3D 1H MR Spectroscopy in Multiple Sclerosis.
多发性硬化症中的串行脑 3D 1H 磁共振波谱。
  • 批准号:
    8329898
  • 财政年份:
    2005
  • 资助金额:
    $ 57.2万
  • 项目类别:
Quantifying Radiation-Therapy Brain Injury With 1H-MRS
使用 1H-MRS 量化放射治疗脑损伤
  • 批准号:
    6468780
  • 财政年份:
    2002
  • 资助金额:
    $ 57.2万
  • 项目类别:
Quantifying Radiation-Therapy Brain Injury With 1H-MRS
使用 1H-MRS 量化放射治疗脑损伤
  • 批准号:
    6607178
  • 财政年份:
    2002
  • 资助金额:
    $ 57.2万
  • 项目类别:
DEVELOPMENT OF ADVANCED CHEMICAL SHIFT IMAGING (CSI) TECHNIQUES
先进化学位移成像 (CSI) 技术的发展
  • 批准号:
    6618860
  • 财政年份:
    2002
  • 资助金额:
    $ 57.2万
  • 项目类别:
DEVELOPMENT OF ADVANCED CHEMICAL SHIFT IMAGING (CSI) TECHNIQUES
先进化学位移成像 (CSI) 技术的发展
  • 批准号:
    6501426
  • 财政年份:
    2001
  • 资助金额:
    $ 57.2万
  • 项目类别:
DEVELOPMENT OF ADVANCED CHEMICAL SHIFT IMAGING (CSI) TECHNIQUES
先进化学位移成像 (CSI) 技术的发展
  • 批准号:
    6318282
  • 财政年份:
    2000
  • 资助金额:
    $ 57.2万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.2万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.2万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 57.2万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.2万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.2万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.2万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.2万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 57.2万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 57.2万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 57.2万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了